Literature DB >> 18819324

[The 2007 World Health Organisation classification of tumours of the central nervous system, comparison with 2000 classification].

B Rychlý1, H Sidlová, D Daniś.   

Abstract

WHO Classification of Tumours of the Central Nervous System from the 2007 is distinguished from the previous 2000 classification by a few conceptual modifications, changes in the terminology and seven newly codified tumour entities. The text shows a short comparison of both classifications emphasising the most important changes from the surgical neuropathology point of view. The newly codified entities are: angiocentric glioma, pilomyxoid astrocytoma, papillary glioneuronal tumor, rosette-forming glioneuronal tumor of the 4th ventricle, papillary tumour of the pineal region, spindle cell oncocytoma and pituicytoma. Mostly, they are rare tumours already known from the literature. Based on new knowledge from the molecular pathology the paragraphs about tumour genetics were markedly changed. The complexity and diversity of tumours of the nervous system is enormous, and, not surprisingly, some problematic questions of classification and grading remain unresolved.

Entities:  

Mesh:

Year:  2008        PMID: 18819324

Source DB:  PubMed          Journal:  Cesk Patol        ISSN: 1210-7875


  7 in total

1.  MicroRNA-21 promotes glioma cell proliferation and inhibits senescence and apoptosis by targeting SPRY1 via the PTEN/PI3K/AKT signaling pathway.

Authors:  Chang Chai; Lai-Jun Song; Shuang-Yin Han; Xi-Qing Li; Ming Li
Journal:  CNS Neurosci Ther       Date:  2018-01-05       Impact factor: 5.243

Review 2.  TET family proteins: new players in gliomas.

Authors:  Er-Bao Bian; Gang Zong; Yong-Sheng Xie; Xiao-Ming Meng; Cheng Huang; Jun Li; Bing Zhao
Journal:  J Neurooncol       Date:  2014-01-07       Impact factor: 4.130

3.  Predictors of long-term survival following postoperative radiochemotherapy for pathologically confirmed suprasellar germ cell tumors.

Authors:  Lei Huo; Xia Wang; Pamela K Allen; Longyun Wang; Yuping Liao; Zaide Han; Liangfang Shen; Qingsong Tu; Meizuo Zhong; Yan Zhuang; Jing Li; Jidong Hong
Journal:  Mol Clin Oncol       Date:  2014-11-20

4.  Significance of human chorionic gonadotropin as a predictor of resistance to standard chemo-radiotherapy for pure germinoma.

Authors:  Akihiro Inoue; Takanori Ohnishi; Shohei Kohno; Shiro Ohue; Shinji Iwata; Shirabe Matsumoto; Masahiro Nishikawa; Saya Ozaki; Yawara Nakamura; Yosuke Mizuno; Riko Kitazawa; Takeharu Kunieda
Journal:  Neurosurg Rev       Date:  2017-08-18       Impact factor: 3.042

5.  A Modified Nucleoside 6-Thio-2'-Deoxyguanosine Exhibits Antitumor Activity in Gliomas.

Authors:  Shengnan Yu; Shiyou Wei; Milan Savani; Xiang Lin; Kuang Du; Ilgen Mender; Silvia Siteni; Themistoklis Vasilopoulos; Zachary J Reitman; Yin Ku; Di Wu; Hao Liu; Meng Tian; Yaohui Chen; Marilyne Labrie; Casey M Charbonneau; Eric Sugarman; Michelle Bowie; Seethalakshmi Hariharan; Matthew Waitkus; Wen Jiang; Roger E McLendon; Edward Pan; Mustafa Khasraw; Kyle M Walsh; Yiling Lu; Meenhard Herlyn; Gordon Mills; Utz Herbig; Zhi Wei; Stephen T Keir; Keith Flaherty; Lunxu Liu; Kongming Wu; Jerry W Shay; Kalil Abdullah; Gao Zhang; David M Ashley
Journal:  Clin Cancer Res       Date:  2021-09-30       Impact factor: 13.801

6.  Anti-metastatic and anti-proliferative activity of eugenol against triple negative and HER2 positive breast cancer cells.

Authors:  Mashan L Abdullah; Mohamed M Hafez; Ali Al-Hoshani; Othman Al-Shabanah
Journal:  BMC Complement Altern Med       Date:  2018-12-05       Impact factor: 3.659

7.  Characterization of Apoptosis in a Breast Cancer Cell Line after IL-10 Silencing

Authors:  Moureq R Alotaibi; Zeinab K Hassan; Salim S Al-Rejaie; Musaad A Alshammari; Mashal M Almutairi; Ali R Alhoshani; Wael A Alanazi; Mohamed M Hafez; Othman A Al-Shabanah
Journal:  Asian Pac J Cancer Prev       Date:  2018-03-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.